Evaluating the Cardiovascular Benefits of Innovator Semaglutide 2.4 mg (Recombinant DNA (r-DNA)) in Patients With Overweight or Obesity: A Critical Review of Current Evidence

Brij Teli, Sunil Sathe, Ravi Kalra, Vivek Mahajan, Ajit Mehta, Rituprana Shinde, Brijesh Kunwar, Pravin R Kahale, Amit Sinkar, Priya Palimkar, Mohan Magdum, Vaishali Deshmukh, Varun Nivargi, Jignesh Parikh, Suraj Patil, Ranjeet Patil, Akshay Kashid, Amit Thopte, Rahul Sawant, Sachin Lakade, Jagjeet Deshmukh, Krishna Dhoot, Bhushan Bari, Anesh Jain, Naresh Munot, Vishnu Mane, Rahul Patil, Kaushik Sheth, Omkar Thopte, Vikrant Khese, Vivek Arya, Shrikant Somani, DB Gaware, Vivek Patel, Vahid Bharmal, Abhijit Khadtare, Anand Ahuja, Satish Sawant, Abhishek Bhargava, Prashant Rajput

Open source

DOI: 10.7759/cureus.111322
Published: 2026-06-22
Container: Cureus
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.7759/cureus.111322,
  title = {Evaluating the Cardiovascular Benefits of Innovator Semaglutide 2.4 mg (Recombinant DNA (r-DNA)) in Patients With Overweight or Obesity: A Critical Review of Current Evidence},
  author = {Brij Teli and Sunil Sathe and Ravi Kalra and Vivek Mahajan and Ajit Mehta and Rituprana Shinde and Brijesh Kunwar and Pravin R Kahale and Amit Sinkar and Priya Palimkar and Mohan Magdum and Vaishali Deshmukh and Varun Nivargi and Jignesh Parikh and Suraj Patil and Ranjeet Patil and Akshay Kashid and Amit Thopte and Rahul Sawant and Sachin Lakade and Jagjeet Deshmukh and Krishna Dhoot and Bhushan Bari and Anesh Jain and Naresh Munot and Vishnu Mane and Rahul Patil and Kaushik Sheth and Omkar Thopte and Vikrant Khese and Vivek Arya and Shrikant Somani and DB Gaware and Vivek Patel and Vahid Bharmal and Abhijit Khadtare and Anand Ahuja and Satish Sawant and Abhishek Bhargava and Prashant Rajput},
  year = {2026},
  journal = {Cureus},
  doi = {10.7759/cureus.111322},
  url = {https://doi.org/10.7759/cureus.111322}
}

RIS

TY  - JOUR
TI  - Evaluating the Cardiovascular Benefits of Innovator Semaglutide 2.4 mg (Recombinant DNA (r-DNA)) in Patients With Overweight or Obesity: A Critical Review of Current Evidence
AU  - Brij Teli
AU  - Sunil Sathe
AU  - Ravi Kalra
AU  - Vivek Mahajan
AU  - Ajit Mehta
AU  - Rituprana Shinde
AU  - Brijesh Kunwar
AU  - Pravin R Kahale
AU  - Amit Sinkar
AU  - Priya Palimkar
AU  - Mohan Magdum
AU  - Vaishali Deshmukh
AU  - Varun Nivargi
AU  - Jignesh Parikh
AU  - Suraj Patil
AU  - Ranjeet Patil
AU  - Akshay Kashid
AU  - Amit Thopte
AU  - Rahul Sawant
AU  - Sachin Lakade
AU  - Jagjeet Deshmukh
AU  - Krishna Dhoot
AU  - Bhushan Bari
AU  - Anesh Jain
AU  - Naresh Munot
AU  - Vishnu Mane
AU  - Rahul Patil
AU  - Kaushik Sheth
AU  - Omkar Thopte
AU  - Vikrant Khese
AU  - Vivek Arya
AU  - Shrikant Somani
AU  - DB Gaware
AU  - Vivek Patel
AU  - Vahid Bharmal
AU  - Abhijit Khadtare
AU  - Anand Ahuja
AU  - Satish Sawant
AU  - Abhishek Bhargava
AU  - Prashant Rajput
PY  - 2026
JO  - Cureus
DO  - 10.7759/cureus.111322
UR  - https://doi.org/10.7759/cureus.111322
ER  -

APA

Teli, B., Sathe, S., Kalra, R., Mahajan, V., Mehta, A., Shinde, R., Kunwar, B., Kahale, P. R., Sinkar, A., Palimkar, P., Magdum, M., Deshmukh, V., Nivargi, V., Parikh, J., Patil, S., Patil, R., Kashid, A., Thopte, A., Sawant, R., Lakade, S., Deshmukh, J., Dhoot, K., Bari, B., Jain, A., Munot, N., Mane, V., Patil, R., Sheth, K., Thopte, O., Khese, V., Arya, V., Somani, S., Gaware, D., Patel, V., Bharmal, V., Khadtare, A., Ahuja, A., Sawant, S., Bhargava, A., & Rajput, P. (2026). Evaluating the Cardiovascular Benefits of Innovator Semaglutide 2.4 mg (Recombinant DNA (r-DNA)) in Patients With Overweight or Obesity: A Critical Review of Current Evidence. Cureus. https://doi.org/10.7759/cureus.111322

Source records

crossref · retrieved 2026-09-26T15:48:29.587Z